OraSure director granted 46,106 restricted shares

Bertrand John D. reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 06/05/2026 - 04:00 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Bertrand John D. reported acquisition or exercise transactions in this Form 4 filing.

OraSure Technologies director John D. Bertrand received a grant of 46,106 shares of Common Stock as an equity award. The shares are restricted and were granted at no cash cost to him.

The award vests in full on the earlier of June 3, 2027 or immediately before the company’s 2027 Annual Meeting of Stockholders, provided he continues serving on the Board. Vesting stops if he voluntarily leaves the Board, meaning unvested shares would not be earned. After this grant, he directly holds 79,767 OraSure shares.

Insider Trade Summary

Grant/Award: 46,106 shares

Grant/Award 1 txn

Insider Bertrand John D.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	46,106	$0.00	$0.00

Holdings After Transaction: Common Stock — 79,767 shares (Direct)

Footnotes (1)

1. F1. Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, which shall vest in full upon the earlier of (i) June 3, 2027, or (ii) immediately prior to the commencement of the Company's 2027 Annual Meeting of Stockholders. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors.

Key Figures

Restricted shares granted: 46,106 shares Grant price per share: $0.0000 per share Shares owned after grant: 79,767 shares +1 more

4 metrics

Restricted shares granted 46,106 shares Common Stock award to director on June 3, 2026

Grant price per share $0.0000 per share Equity award, no cash paid by director

Shares owned after grant 79,767 shares Total direct holdings following the transaction

Vesting date trigger June 3, 2027 Full vesting or earlier immediately before 2027 annual meeting

Key Terms

restricted shares, Stock Award Plan, vest in full, Annual Meeting of Stockholders, +1 more

5 terms

restricted shares financial

"Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Stock Award Plan financial

"Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan"

A stock award plan is a company program that gives employees, executives or board members shares or the right to shares as part of their pay, usually becoming theirs over time or when certain goals are met. Investors care because these awards can change how many shares exist (dilution), signal how management is being motivated, and affect future earnings per share—think of it as paying staff with future slices of the company’s pie to align incentives.

vest in full financial

"which shall vest in full upon the earlier of (i) June 3, 2027"

Annual Meeting of Stockholders financial

"immediately prior to the commencement of the Company's 2027 Annual Meeting of Stockholders"

Board of Directors financial

"if the named individual voluntarily ceases to serve as a member of the Board of Directors"

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did OraSure Technologies (OSUR) director John D. Bertrand report on this Form 4?

He reported receiving 46,106 shares of OraSure Technologies Common Stock as an equity award. The grant was made at no cash cost to him and is structured as restricted shares that vest based on continued Board service through 2027.

How many OraSure Technologies (OSUR) shares did John D. Bertrand acquire in this award?

He acquired 46,106 shares of Common Stock as a grant, not a market purchase. These shares are restricted and will only fully vest if he continues serving on OraSure’s Board until the specified 2027 vesting trigger.

When do John D. Bertrand’s newly granted OraSure (OSUR) restricted shares vest?

The restricted shares vest in full on the earlier of June 3, 2027 or immediately prior to the start of OraSure’s 2027 Annual Meeting of Stockholders. Continuous service on the Board until that time is required for full vesting.

What happens to the OraSure (OSUR) restricted shares if John D. Bertrand leaves the Board?

Vesting stops immediately if he voluntarily ceases to serve as a Board member. In that case, any unvested restricted shares from this grant would not continue vesting, limiting the award to shares already vested at his departure.

How many OraSure Technologies (OSUR) shares does John D. Bertrand hold after this transaction?

Following the restricted share grant, he directly holds 79,767 shares of OraSure Common Stock. This figure includes the newly awarded 46,106 restricted shares, which are subject to vesting conditions tied to his continued Board service through 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bertrand John D.

(Last) (First) (Middle)

C/O ORASURE TECHNOLOGIES, INC.

220 E. FIRST STREET

(Street)

BETHLEHEM PENNSYLVANIA 18015

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ORASURE TECHNOLOGIES INC [ OSUR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/03/2026		A(1)		46,106	A	$0	79,767	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, which shall vest in full upon the earlier of (i) June 3, 2027, or (ii) immediately prior to the commencement of the Company's 2027 Annual Meeting of Stockholders. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors.

	/s/ Michele Anthony, Attorney-in-Fact	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)